Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy

被引：0
|
作者：
Wang, Lei
Xiao, Yufeng
Master, Rohan P.
Jin, Zeng
Patel, Urvi M.
Luo, Yuewan
Zhou, Daohong
Zheng, Guangrong
Zhang, Weizhou
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2326
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2326
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy
    Wang, Lei
    Xiao, Yufeng
    Master, Rohan
    Luo, Yuewan
    Zheng, Guangrong
    Zhou, Daohong
    Zhang, Weizhou
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [2] Proteolysis-Targeting Chimera (PROTAC) Therapy for Cancer
    Petrylak, Daniel P.
    ONCOLOGY-NEW YORK, 2021, 35 (12): : 849 - 851
  • [3] Brd4 proteolysis-targeting chimera nanoparticles sensitized colorectal cancer chemotherapy
    He, Yihong
    Ju, Yan
    Hu, Yuzhu
    Wang, Bilan
    Che, Siyao
    Jian, Yue
    Zhuo, Weiling
    Fu, Xianghui
    Cheng, Yongzhong
    Zheng, Songping
    Huang, Ning
    Qian, Zhiyong
    Liu, Jiagang
    Zhou, Peizhi
    Gao, Xiang
    JOURNAL OF CONTROLLED RELEASE, 2023, 354 : 155 - 166
  • [4] Advancing Strategies for Proteolysis-Targeting Chimera Design
    Li, Minglei
    Zhi, Ying
    Liu, Bo
    Yao, Qingqiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (04) : 2308 - 2329
  • [5] Proteolysis-targeting chimera molecules targeting SHP2
    Yu, Dandan
    Zheng, Mengzhu
    Liu, Yang
    Chen, Lixia
    Li, Hua
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (08) : 587 - 600
  • [6] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
    Li, Xin
    Song, Yongcheng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [7] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
    Xin Li
    Yongcheng Song
    Journal of Hematology & Oncology, 13
  • [8] Proteolysis-targeting chimera (PROTAC) compounds to degrade S100A4 and inhibit breast cancer metastasis
    Du, M.
    Wang, G.
    Ismail, T. M.
    Crick, R.
    Barraclough, R.
    Daimark, B. H.
    Nixon, G.
    Rudland, P.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
    Kim, Kidae
    Lee, Dong Ho
    Park, Sungryul
    Jo, Seung-Hyun
    Ku, Bonsu
    Park, Sung Goo
    Park, Byoung Chul
    Jeon, Yeong Uk
    Ahn, Sunjoo
    Kang, Chung Hyo
    Hwang, Daehee
    Chae, Sehyun
    Ha, Jae Du
    Kim, Sunhong
    Hwang, Jong Yeon
    Kim, Jeong-Hoon
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
    Lospinoso Severini, Ludovica
    Bufalieri, Francesca
    Infante, Paola
    Di Marcotullio, Lucia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
12345